Aaron Hunt
Overview
Explore the profile of Aaron Hunt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miller E, Schweitzer S, Ahmed P, Robbins C, Lanzillotta-Rangeley J, Hunt A
BMC Public Health
. 2024 Dec;
24(1):3531.
PMID: 39696075
Background: Rural communities are disproportionately affected by substance use disorder (SUD) and public stigma impedes access to and utilization of treatment and support services. Methods: This study compares data from...
2.
Middendorf A, Hunt A, Vanden Hull A, Van Gilder D, Miller E, Pinto S
Innov Pharm
. 2024 Nov;
15(3).
PMID: 39483506
Community pharmacists are often the most accessible member of the healthcare team to many patients and can play a key role in managing their chronic conditions, such as diabetes or...
3.
Miller E, Hunt A, Middendorf A, Van Gilder D, Blanchette A, Sirek A, et al.
Explor Res Clin Soc Pharm
. 2024 Sep;
15:100490.
PMID: 39257534
Background: Access to healthcare services is a major barrier to residents of the rural state of South Dakota. As a highly accessible member of the healthcare team, outpatient pharmacists can...
4.
Chung J, Bundy J, Khan S, Hunt A, Carroll S, Ali A, et al.
J Stroke Cerebrovasc Dis
. 2024 Jul;
33(9):107850.
PMID: 38971481
Intro: Current guidelines for acute ischemic stroke recommend timely administration of intravascular thrombolytic therapy to promote functional and neurologic outcomes. Tenecteplase is an emerging off-label therapy for this indication and...
5.
Wang Y, Hunt A, Danziger L, Drwiega E
Antibiotics (Basel)
. 2024 May;
13(5).
PMID: 38786164
infection (CDI) is an intestinal infection that causes morbidity and mortality and places significant burden and cost on the healthcare system, especially in recurrent cases. Antibiotic overuse is well recognized...
6.
Hunt A, Danziger L, Johnson S, Skinner A
Open Forum Infect Dis
. 2024 Apr;
11(4):ofae153.
PMID: 38665169
Vancomycin and fidaxomicin taper regimens were the most common treatment strategies employed but nearly half of patients (40/83) referred to our infection (CDI) clinic did not require further treatment. The...
7.
Hunt A, Drwiega E, Wang Y, Danziger L
Am J Health Syst Pharm
. 2024 Mar;
81(15):e402-e411.
PMID: 38470061
Purpose: To review the composition, preparation, proposed mechanism of action, safety, efficacy, and current place in therapy of Rebyota (fecal microbiota, live-jslm). Summary: As the first agent in a new...
8.
Omisakin O, Ulrich-Schad J, Hunt A, Givens J, Beacham M
Prev Med Rep
. 2023 Sep;
36:102390.
PMID: 37719795
Introduction: Since its emergence in December 2019, COVID-19 has caused millions of deaths worldwide. While vaccines are largely available in most places, including the United States (U.S.), vaccine uptake is...
9.
Pinto S, Kotschevar C, Hunt A, Middendorf A, Robbins C, Miller E, et al.
Pharmacy (Basel)
. 2022 Dec;
10(6).
PMID: 36548334
Background: Pharmacists can offer medication expertise to help better control diabetes and cardiovascular disease (CVD) and improve patient outcomes, particularly in rural communities. This project evaluated the impact of an...
10.
Miller E, Ball J, Emery M, Robbins C, Daniel J, Ahmed P, et al.
J Am Pharm Assoc (2003)
. 2022 Oct;
63(1):366-373.
PMID: 36207271
Background: Deaths from drug-related overdoses are increasing. Rural areas continue to have fewer accessible resources than urban areas. The START-SD (Stigma, Treatment, Avoidance, and Recover in Time - South Dakota)...